Recordati Industria Chimica e Farmaceutica Statistics

Total Valuation

Recordati Industria Chimica e Farmaceutica has a market cap or net worth of GBP 9.64 billion. The enterprise value is 10.77 billion.

Market Cap	9.64B
Enterprise Value	10.77B

Important Dates

The next estimated earnings date is Friday, February 21, 2025.

Earnings Date	Feb 21, 2025
Ex-Dividend Date	Nov 18, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.01%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	96.09M

Valuation Ratios

The trailing PE ratio is 27.38.

PE Ratio	27.38
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.99, with an EV/FCF ratio of 26.05.

EV / Earnings	30.59
EV / Sales	5.61
EV / EBITDA	14.99
EV / EBIT	18.24
EV / FCF	26.05

Financial Position

The company has a current ratio of 1.38, with a Debt / Equity ratio of 0.84.

Current Ratio	1.38
Quick Ratio	0.90
Debt / Equity	0.84
Debt / EBITDA	1.85
Debt / FCF	3.16
Interest Coverage	8.61

Financial Efficiency

Return on equity (ROE) is 23.50% and return on invested capital (ROIC) is 12.47%.

Return on Equity (ROE)	23.50%
Return on Assets (ROA)	10.35%
Return on Capital (ROIC)	12.47%
Revenue Per Employee	423,868
Profits Per Employee	79,034
Employee Count	4,455
Asset Turnover	0.54
Inventory Turnover	1.64

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +10.58% in the last 52 weeks. The beta is 0.40, so Recordati Industria Chimica e Farmaceutica's price volatility has been lower than the market average.

Beta (5Y)	0.40
52-Week Price Change	+10.58%
50-Day Moving Average	51.81
200-Day Moving Average	50.93
Relative Strength Index (RSI)	72.01
Average Volume (20 Days)	9,020

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Recordati Industria Chimica e Farmaceutica had revenue of GBP 1.89 billion and earned 352.10 million in profits. Earnings per share was 1.68.

Revenue	1.89B
Gross Profit	1.33B
Operating Income	581.21M
Pretax Income	451.95M
Net Income	352.10M
EBITDA	696.66M
EBIT	581.21M
Earnings Per Share (EPS)	1.68

Full Income Statement

Balance Sheet

The company has 195.57 million in cash and 1.31 billion in debt, giving a net cash position of -1.11 billion.

Cash & Cash Equivalents	195.57M
Total Debt	1.31B
Net Cash	-1.11B
Net Cash Per Share	n/a
Equity (Book Value)	1.56B
Book Value Per Share	7.57
Working Capital	290.34M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 441.37 million and capital expenditures -27.82 million, giving a free cash flow of 413.55 million.

Operating Cash Flow	441.37M
Capital Expenditures	-27.82M
Free Cash Flow	413.55M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 70.63%, with operating and profit margins of 30.78% and 18.65%.

Gross Margin	70.63%
Operating Margin	30.78%
Pretax Margin	23.93%
Profit Margin	18.65%
EBITDA Margin	36.89%
EBIT Margin	30.78%
FCF Margin	21.90%

Dividends & Yields

This stock pays an annual dividend of 1.04, which amounts to a dividend yield of 1.89%.

Dividend Per Share	1.04
Dividend Yield	1.89%
Dividend Growth (YoY)	1.90%
Years of Dividend Growth	12
Payout Ratio	58.40%
Buyback Yield	-0.01%
Shareholder Yield	1.88%
Earnings Yield	3.65%
FCF Yield	4.29%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Recordati Industria Chimica e Farmaceutica has an Altman Z-Score of 4.51.

Altman Z-Score	4.51
Piotroski F-Score	n/a